Literature DB >> 28255066

Children's End-of-Life Health Care Use and Cost.

Kimberley Widger1,2, Hsien Seow3, Adam Rapoport2,4,5, Mathieu Chalifoux6, Peter Tanuseputro6,7.   

Abstract

BACKGROUND AND OBJECTIVES: Heath care use and cost for children at the end of life is not well documented across the multiple sectors where children receive care. The study objective was to examine demographics, location, cause of death, and health care use and costs over the last year of life for children aged 1 month to 19 years who died in Ontario, Canada.
METHODS: We conducted a population-based retrospective cohort study using administrative databases to determine the characteristics of and health care costs by age group and cause of death over a 3-year period from 2010 to 2013.
RESULTS: In our cohort of 1620 children, 41.6% died of a chronic disease with wide variation across age groups. The mean health care cost over the last year of life was $78 332 (Canadian) with a median of $18 450, reflecting the impact of high-cost decedents. The mean costs for children with chronic or perinatal/congenital illnesses nearly tripled over the last 4 months of life. The majority of costs (67.0%) were incurred in acute care settings, with 88.0% of children with a perinatal/congenital illness and 79.7% with a chronic illness dying in acute care. Only 33.4% of children received home care in the last year of life.
CONCLUSIONS: Children in Ontario receive the majority of their end-of-life care in acute care settings at a high cost to the health care system. Initiatives to optimize care should focus on early discussion of the goals of care and assessment of whether the care provided fits with these goals.
Copyright © 2017 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2017        PMID: 28255066     DOI: 10.1542/peds.2016-2956

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Cost-effectiveness Analysis of Screening Extremely Low Birth Weight Children for Hepatoblastoma Using Serum Alpha-fetoprotein.

Authors:  Rebecca MacDonell-Yilmaz; Kelly Anderson; Bradley DeNardo; Philippa Sprinz; William V Padula
Journal:  J Pediatr       Date:  2020-05-26       Impact factor: 4.406

2.  The journey through care: study protocol for a longitudinal qualitative interview study to investigate the healthcare experiences and preferences of children and young people with life-limiting and life-threatening conditions and their families in the West Midlands, UK.

Authors:  Sarah Mitchell; Anne-Marie Slowther; Jane Coad; Jeremy Dale
Journal:  BMJ Open       Date:  2018-01-21       Impact factor: 2.692

3.  "Death is inevitable - a bad death is not" report from an international workshop.

Authors:  Adir Shaulov; Kassim Baddarni; Nathan Cherny; Dorith Shaham; Pesach Shvartzman; Rotem Tellem; A Mark Clarfield
Journal:  Isr J Health Policy Res       Date:  2019-11-12

4.  Advancing pediatric palliative care in a low-middle income country: an implementation study, a challenging but not impossible task.

Authors:  Ximena Garcia-Quintero; Luis Gabriel Parra-Lara; Angelica Claros-Hulbert; Maria Isabel Cuervo-Suarez; Wendy Gomez-Garcia; Francois Desbrandes; Natalia Arias-Casais
Journal:  BMC Palliat Care       Date:  2020-11-06       Impact factor: 3.234

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.